OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
January 02, 2010
From healthcare to corruption to life expectancy, here's what we can learn from the past decade.
Directors and staff miss the mark when it comes to following procedures.
January 01, 2010
It's customary among columnists to begin a new year with some predictions about what's to come. We don't honour that custom every year, but with what the contract services industry went through in 2009, it seemed appropriate to share thoughts on what we expect for 2010.
December 31, 2009
BioNanomatrix (Philadelphia) names Edward Erickson president and CEO; and More.
December 23, 2009
Merck & Co. Acquires Avecia Biologics; Ambrilia Biopharma Closes Manufacturing Facility; And More.
December 17, 2009
Also, Abbott to acquire Starlims Technologies; GSK Biologicals to form alliance with Intercell.
December 10, 2009
Company and People Notes: Also, Pfizer and Protalix enter agreement; Watson acquires Arrow Group; and more.
December 03, 2009
Also, Merck & Co. extends collaboration with Idera Pharmaceuticals; Pfizer establishes R&D center in China; more...
December 02, 2009
Particularly in a more connected world, individual contributions can make a difference.
Dumbed-down presentations and poor speaker selections are destroying a valuable industry tool.